Revenue per share, maybe half a cent, as you say, true enough. But you are forgetting to apply the PE ratio. I use a very appropriate biotech value of 20:1, thus a half cent a share revenue equates to 10 cents a share in share price.
An easy mistake to make, maybe you misunderstood what i was saying.
Revenue per share, maybe half a cent, as you say, true enough....
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.099K | 707.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 85992113 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 63266804 | 17 |
View Market Depth
| Last trade - 15.59pm 30/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |